Shear Wave Elastography for Predicting Extracorporeal Shock Wave Lithotripsy Outcomes in Pediatric Renal Stones
SWE-ESWL
Evaluating Shear Wave Elastography as a Predictor of Extracorporeal Shock Wave Lithotripsy Outcomes and Stone Composition in Children "A Prospective Study"
1 other identifier
observational
108
1 country
1
Brief Summary
This prospective study aims to evaluate the role of shear wave elastography (SWE) as a non-invasive and radiation-free tool for predicting the success of extracorporeal shock wave lithotripsy (ESWL) in pediatric patients with renal stones. Currently, computed tomography (CT)-derived Hounsfield units (HU) are used to estimate stone hardness; however, repeated radiation exposure is a concern in children. SWE may provide an alternative method by assessing stone stiffness using ultrasound. Pediatric patients under 18 years with renal stones (6-20 mm) scheduled for ESWL will be included. SWE measurements will be performed prior to treatment, and patients will be followed for 3 months to assess treatment outcomes. The primary outcome is ESWL success, while secondary outcomes include correlation between SWE and HU, number of ESWL sessions required, prediction of stone composition, and assessment of the relationship between SWE measurements and stone composition. This study seeks to determine whether SWE can serve as a reliable predictor of ESWL outcomes, correlate with stone composition, and reduce the need for radiation-based imaging in children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 2, 2025
CompletedFirst Submitted
Initial submission to the registry
March 24, 2026
CompletedFirst Posted
Study publicly available on registry
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
April 1, 2026
March 1, 2026
5 months
March 24, 2026
March 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
ESWL Success Rate
Treatment success defined as absence of stone fragments or presence of clinically insignificant residual fragments ≤2 mm on imaging, without symptoms, obstruction, or urinary tract infection.
3 months with maximum 3 sessions ESWL
Secondary Outcomes (1)
Secondary Outcomes Related to SWE and ESWL
Up to 3 months after ESWL
Study Arms (1)
Pediatric Patients Undergoing ESWL
Pediatric patients (\<18 years) with renal stones (6-20 mm) undergoing extracorporeal shock wave lithotripsy (ESWL). All patients will undergo baseline shear wave elastography (SWE) assessment prior to treatment. Patients will be followed for 3 months to evaluate ESWL success and its correlation with SWE measurements, Hounsfield units (HU), and stone composition.
Eligibility Criteria
Pediatric patients under 18 years of age diagnosed with renal stones measuring 6-20 mm and scheduled for extracorporeal shock wave lithotripsy (ESWL). Patients will be recruited from the outpatient clinic and followed for 3 months. Proper history, examination and basic laboratory investigations (CBC, coagulation profile, kidney and Liver functions, urine analysis and urine culture and sensitivity) will be performed for all participants. Low dose CTUT will be performed as usual for all patient to record stone location, size (maximum longitudinal and transverse dimensions), and HU. Renal stone elastography values will be measured by a single radiologist using grayscale renal US and SWE. SWE measurements will be performed once prior to ESWL. A Philips EPİQ7 system (Philips Medical Systems, Bothell, WA) with a 1-5-MHz abdominal probe will be used for the procedure.
You may qualify if:
- Single Renal stones measured 6- 20 mm in maximal dimension.
- ESWL will be planned as the first line of treatment.
You may not qualify if:
- Patients with internal ureteral stent.
- ureteral stones.
- abnormal renal anatomies (pelvic kidney, horseshoe kidney, and rotational anomaly).
- active UTI at time of ESWL.
- coagulopathy .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
faculty of medicine Beni Suef university hospital
Banī Suwayf, 62511, Egypt
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of urology faculty of medicine Beni Suef university
Study Record Dates
First Submitted
March 24, 2026
First Posted
April 1, 2026
Study Start
December 2, 2025
Primary Completion (Estimated)
May 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
April 1, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share